Stay updated with breaking news from Germline Mutations. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Kara N. Maxwell, MD, PhD, discusses the prevalence of germline mutations in racially diverse cohorts of patients with metastatic prostate cancer.
![[Complimentary CLE Webinar] 2023 Brings Multiple Waves of Additional Studies Regarding Mesotheliomas and Other Cancers Caused Solely by Genomic Factors - July 18th, 2:00 pm - 3:30 pm ET | Perrin Conferences, LLC - Vimarsana News](https://jdsupra-static.s3.amazonaws.com/profile-images/hr.16159_4300.jpg)
Topics for discussion include: - The Big Picture Status of Genomics in Mesothelioma Litigation - Recent Statistical Analyses of Genetically Engineered Mice Reject...
Experts on advanced ovarian cancer give detailed insights on the role of biomarker testing and identify important biomarkers.
Robert L Coleman, MD, FACOG, FACS, and Bradley J Monk, MD, FACOG, FACS, provide an overview of advanced ovarian cancer and discuss its prevalence and diagnosis process.